Alberta Innovates is excited to announce the Real-World Evaluation of Cannabis-Based Medicines (mCannabis.RealWorld) Program. The program is a novel enabling mechanism to address urgent clinical or policy knowledge gaps related to the efficacy and safety of cannabis in a real-world setting. Expected outcomes include: 1) generating real-world evidence to inform clinical or policy decisions, 2) building collaborative connections, 3) improving Canadian competitiveness, 4) enabling rapid knowledge generation, 5) creating accessible new data sources, and 5) enhancing patient-centred care.
A unique feature of the mCannabis.RealWorld Program is the opportunity to engage with a panel of industry members, academics, clinicians, research facilitators, and other health care agents to strengthen full proposals as well as identify collaborative opportunities.
Alberta Innovates will contribute up to $300,000 CAD to support approved projects over a maximum term of 24 months. Successful Expression of Interest applicants will be eligible to receive up to $10,000 CAD to support proposal development.
EOI deadline: October 7th, 2020 - Apply Now!
Those who are interested are encouraged to contact Senior Business Partner:
Sunil Rajput at firstname.lastname@example.org.